ArticleImmunologic research2024
SPDYC serves as a prognostic biomarker related to lipid metabolism and the immune microenvironment in breast cancer.
Xinxin Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it